Indian companies are paying up to 25% more for China APIs

Key APIs have become 12-25% costlier in the past few days amid possible supply disruptions that may squeeze margins and raise drug prices, industry executives said. This could also lead to drug shortages, they warned

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FxARazG
via IFTTT